name: Basis for allelic phase:Type:Pt:^Patient:Nom:*


name: Escherichia coli shiga-like toxin 1+2:PrThr:Pt:Stool:Ord:IA


name: Views 1 or 2:Find:Pt:Upper extremity>Wrist:Doc:XR


name: Views GE 2:Find:Pt:Upper extremity:Doc:XR


name: Views GE 3:Find:Pt:Lower extremity>Tibia+Fibula:Doc:XR


name: 6-Thioguanine & 6-methylmercaptopurine panel:-:Pt:RBC:-


name: 3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone:SCnc:24H:Urine:Qn


name: Natural killer cell cytotoxicity.50:1 effector to target cell ratio/Positive control:RelACnc:Pt:Bld MC:Qn


name: Natural killer cell cytotoxicity.25:1 effector to target cell ratio/Positive control:RelACnc:Pt:Bld MC:Qn


name: Natural killer cell cytotoxicity.12.5:1 effector to target cell ratio/Positive control:RelACnc:Pt:Bld MC:Qn


name: Blood velocity-time integral.E wave:Len:Pt:Mitral valve.leaflet.tip:Qn:US.doppler


name: Reticulocytes.mid light scatter/Reticulocytes.total:NFr:Pt:Bld:Qn:Automated count


name: Ganglioside GM4 Ab.IgG+IgM:PrThr:Pt:Ser:Ord:Line blot


name: Ganglioside GM4 Ab.IgG:PrThr:Pt:Ser:Ord:Line blot


name: Ganglioside GD3 Ab.IgM:PrThr:Pt:Ser:Ord:Line blot


name: Education note:Find:Pt:{Setting}:Doc:Reproductive endocrinology and infertility


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Reproductive endocrinology and infertility


name: Referral note:Find:Pt:{Setting}:Doc:Reproductive endocrinology and infertility


name: Dengue virus 1+3 RNA:PrThr:Pt:Ser:Ord:Probe.amp.tar


name: Level 3 emergency medical services patient care report - recommended CDA R1 & R2 sections:-:Pt:{Setting}:-


name: SDHB & SDHC & SDHD gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: SDHD gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: VHL gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Procedure note:Find:Pt:{Setting}:Doc:Neonatal perinatal medicine


name: Initial evaluation note:Find:Pt:Telephone encounter:Doc:{Role}


name: Oxygen consumption/Ideal body weight:ArVRat:Pt:^Patient:Qn


name: Obstructive apnea duration:Time:Pt:Respiratory system:Qn


name: Inspiratory hold time setting:Time:Pt:Ventilator:Qn


name: Expiratory hold time setting:Time:Pt:Ventilator:Qn


name: Central apnea duration:Time:Pt:Respiratory system:Qn


name: Airway pressure delta setting:PressDiff:Pt:Ventilator:Qn


name: Airway pressure backup setting:Pres:Pt:Ventilator:Qn


name: Volume.inspired per minute^on ventilator:VRat:1M:Respiratory system:Qn


name: Volume.expired per minute^on ventilator:VRat:1M:Respiratory system:Qn


name: Mixed apnea duration:Time:Pt:Respiratory system:Qn


name: Oxygen consumption/Body surface area:ArVRat:Pt:^Patient:Qn


name: 2 or 3 views and views W flexion and W extension and views oblique


name: Physical medicine and rehabilitation Nurse


name: Centers for Medicare and Medicaid Assessment


name: Natural killer cell cytotoxicity.3.13:1 effector to target cell ratio


name: UPPS-P Impulsive Behavior Scale for Children


name: Strengths and Weaknesses of ADHD Symptoms and Normal Behavior Rating Scale (SWAN)


name: Spinal cord injury medicine Physician assistant


name: Relationships of Indoor, Outdoor, and Personal Air Questionnaire


name: Physical medicine and rehabilitation Resident


name: Physical medicine and rehabilitation Attending


name: Physical medicine and rehabilitation Case manager


name: Oral and maxillofacial surgery Attending


name: Lifetime Trauma and Victimization History survey


name: Hematology+Medical oncology Nurse practitioner


name: Gradient strip for antimicrobial resistance detection


name: Gastroenterology Clinical nurse specialist


name: Colon and rectal surgery Nurse practitioner


name: Natural killer cell cytotoxicity.6.25:1 effector to target cell ratio


name: Natural killer cell cytotoxicity.50:1 effector to target cell ratio


name: Natural killer cell cytotoxicity.25:1 effector to target cell ratio


name: Natural killer cell cytotoxicity.12.5:1 effector to target cell ratio


name: Multisection^W contrast IV && Multisection^WO & W contrast IV


name: Greater than 4 views and greater than 1 view W R-bending and W L-bending


name: (AP^W R-bending and W L-bending) and (lateral^W flexion and W extension)


name: AP and odontoid and lateral W flexion+W extension


name: AP and oblique and lateral W flexion+W extension


name: AP and oblique and odontoid and lateral W flexion+W extension


name: AP and lateral and oblique and W manual stress


name: 2 or 3 views and views W flexion and W extension


name: (View Sunrise) + (View tunnel^W standing)


name: oblique and (views W right bending and W left bending)


name: post dose gonadotropin releasing hormone


name: atorvastatin, acetylsalicylic acid and perindopril


name: ZINC OXIDE 2.1 mg in 1 mL / TITANIUM DIOXIDE 4.7 mg in 1 mL TOPICAL STICK [REVLON PHOTOREADY INSTA-FIX MAKEUP]


name: TITANIUM DIOXIDE 4 mg in 1 mL TOPICAL PASTE [Revlon New Complexion One-Step Perfect Make-Up]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL LOTION [La Roche Posay Laboratoire Dermatologique Toleriane Double Repair Moisturizer UV Broad Spectrum SPF 30 Sunscreen]


name: ALLANTOIN 0.1 mg in 1 mL / GLYCERIN 0.25 mg in 1 mL TOPICAL CREAM [Melano Out Cream]


name: GLYCERIN 8 mg in 1 mL / ALLANTOIN 2 mg in 1 mL / MINERAL OIL 2 mg in 1 mL TOPICAL CREAM [Melano Out Mask]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL CREAM [Kiehls Since 1851 Super Multi Corrective Broad Spectrum SPF 30 Sunscreen]


name: CATHETER,INTERMITTENT 8FR COLOPLAST #28408


name: CATHETER,SUCTION,WHISTLE TIP 14-16FR KIT BARD #140020


name: DRESSING,CUTIMED SILTEC SORBACT 5IN X 5IN #7992901


name: DRESSING,MEPILEX BORDER FLEX 5IN X 6.3IN


name: DRESSING,MEPILEX BORDER FLEX 6IN X 7.5IN


name: DRESSING,MEPILEX BORDER HEEL 7.3IN X 9.5IN


name: DRESSING,SORBION SACHET MULTI STAR 3.5IN


name: DRESSING,SORBION SACHET MULTI STAR 5.5IN


name: FEEDING BAG W/GRAVITY SET ENFIT COVIDIEN #702500


name: FEEDING BAG W/PUMP SET ENFIT COVIDIEN #762055


name: STOCKINETTE,COTTON,TUBULAR 5IN X 25YD ROLL


name: SUCTION SET,SUCTION PRO 72 14FR CLOSED CATHETER #Z116N-14


name: TUBING,SUCTION 3/16IN X 10FT COVIDIEN #8888301523


name: UNDERPAD,BED 30IN X 36IN KENDALL #P3036C


name: UNDERPAD,BED EXTRASORB 30IN X 36IN MEDLINE #3036A


name: ZINC OXIDE 2 g in 50 mL / TITANIUM DIOXIDE 0.8 g in 50 mL TOPICAL CREAM [GIN-III Alpha and Omega GIN Sun]


name: HYALURONATE SODIUM 0.1 mg in 1 mL TOPICAL GEL [XR CELLULAR MAGIC]


name: NIACINAMIDE 0.40 g in 20 mL / ADENOSINE 0.008 g in 20 mL TOPICAL CREAM [MU LAB TURN AROUND 2W Refresh Ex]


name: Octinoxate 0.065 g in 1 g / Zinc Oxide 0.036 g in 1 g TOPICAL LOTION [ESIKA PRO INSTANT PERFECTION 3 EN 1 FACE REFINING FOUNDATION SPF 25 CLARO 1 - BEIGE]


name: Kaolin 0.002 g in 0.2 g TOPICAL PATCH [MEFACTORY PIG COLLAGEN 1STEP PIGGY NOSE PACK]


name: camphor / Capsicum extract / levomenthol


name: dehydroepiandrosterone (prasterone) compounding powder


name: Ulticare Insulin Syringe and Needles, 1 cc x


name: MEBENDAZOLE 19.8 kg in 20 kg NOT APPLICABLE POWDER [X]


name: Prednisolone Na Phosphate-Na Sulfacetamide


name: Adult Multivitamin with Vitamin D3 Gummies


name: Mult-Vitamin/Fluoride 0.5 MG Oral Tablet Chewable


name: Contour Next ONE Blood Glucose Monitor System


name: Acetaminophen/Dextromethorphan Hydrobromide/Phenylephrine Hydrochloride;Acetaminophen/Diphenhydramine Hydrochloride/Phenylephrine Hydrochloride 650 MG/30 ML-20 MG/30 ML-10 MG/30 ML; 650 MG/30 ML-25 MG/30 ML-10 MG/30 ML Oral Solution


name: Benzalkonium Chloride;Dexamethasone 0.0013 GM/1 ML; 0.5 MG Multiple Routes Kit


name: palm oil TOPICAL SPRAY, NON-AEROSOL (ML)


name: Testosterone, Micronized;Cream Base NA Multiple Routes Kit


name: Dimethicone;Triamcinolone Acetonide 5%; 0.1% Multiple Routes Kit [ELLZIA PAK]


name: dihydrocodeine and other non-opioid analgesics


name: tramadol, dexketoprofen drug combination


name: tramadol and other non-opioid analgesics


name: Glucagon-like peptide-1 (GLP-1) analogues


name: Opioids in combination with non-opioid analgesics


name: Sodium-glucose co-transporter 2 (SGLT2) inhibitors


name: Belladonna/Bloodroot/Blue Flag/Menthol;Sumatriptan Succinate 1.33%-1.33%-1.33%-50%; 50 MG Multiple Routes Kit [MIGRAINE PACK]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL AEROSOL, SPRAY [Solar Defense Body]


name: TITANIUM DIOXIDE 25 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL CREAM [Solar Defense Tinted]


name: TITANIUM DIOXIDE 30 mg in 1 mL / ZINC OXIDE 70 mg in 1 mL TOPICAL CREAM [Solar Defense Non Tinted]


name: lidocaine/kinesiology tape 5 % TOPICAL KIT


name: AVOBENZONE 3 kg in 100 mL / HOMOSALATE 10 kg in 100 mL / OCTINOXATE 7.5 kg in 100 mL / OCTISALATE 5 kg in 100 mL TOPICAL CREAM [Super Power Sunscreen Mousse SPF 50 Supergoop]


name: AVOBENZONE 3 g in 100 g / OCTINOXATE 7.5 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL LOTION


name: Niacinamide 1 g in 50 mL / Dimethicone 0.85 g in 50 mL / Panthenol 0.1 g in 50 mL TOPICAL CREAM [Cellapy A.Repair Plus]


name: TITANIUM DIOXIDE 9.0 g in 100 mL / ZINC OXIDE 6.3 g in 100 mL TOPICAL CREAM [YOUR SKIN BUT BETTER CC ILLUMINATION DEEP]


name: Glycerin 3.43 g in 50 mL TOPICAL CREAM [VITAMIN B5]


name: OCTINOXATE 7.5 g in 100 mL / OXYBENZONE 2 g in 100 mL TOPICAL CREAM [Timeless Illuminating Makeup SPF 30 Alabaster Beige Merle Norman]


name: OCTINOXATE 7.5 g in 100 mL / OXYBENZONE 2 g in 100 mL TOPICAL CREAM [Timeless Illuminating Makeup SPF 30 Pure Beige Merle Norman]


name: Insertion of anterior segment aqueous drainage device, with creation of intraocular reservoir, internal approach, into the supraciliary space


name: Device evaluation and interrogation of intraocular retinal electrode array (eg, retinal prosthesis), in person, including reprogramming and visual training, when performed, with review and report by a qualified health care professional


name: Device evaluation, interrogation, and initial programming of intraocular retinal electrode array (eg, retinal prosthesis), in person, with iterative adjustment of the implantable device to test functionality, select optimal permanent programmed values with analysis, including visual training, with review and report by a qualified health care professional


name: Retinal polarization scan, ocular screening with on-site automated results, bilateral


name: Visual evoked potential, testing for glaucoma, with interpretation and report


name: Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use


name: Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use


name: Dengue vaccine, quadrivalent, live, 3 dose schedule, for subcutaneous use


name: Oncology (ovarian) biochemical assays of five proteins (apolipoprotein A-1, CA 125 II, follicle stimulating hormone, human epididymis protein 4, transferrin), utilizing serum, algorithm reported as a likelihood score


name: Red blood cell antigen typing, DNA, human erythrocyte antigen gene analysis of 35 antigens from 11 blood groups, utilizing whole blood, common RBC alleles reported


name: Nonconformance to editorial policy component


name: Osteopathic cranial manipulative medicine


name: Anion gap based on sodium, potassium, chloride and bicarbonate ions calculation technique


name: Anion gap based on sodium, chloride and bicarbonate ions calculation technique


name: Positron emission tomography with computed tomography of brain using florbetaben (18-F)


name: Dual energy X-ray absorptiometry of bone of spine


name: Fluoroscopy guided sclerotherapy of vascular malformation of orbit with contrast


name: EMR (endoscopic mucosal resection) of gastrointestinal tract


name: Post-exposure herpesvirus infection prophylaxis


name: Insertion of malleable metallic restoration into tooth


name: Fear of having cancer of digestive system


name: Fluoroscopic angiography of peroneal artery using contrast with insertion of drug eluting stent


name: Fluoroscopy guided percutaneous transluminal angioplasty of tibioperoneal trunk with contrast


name: Magnetic resonance spectroscopy of brain without contrast


name: Postoperative blood pressure measurement


name: Phototherapy of neonate using ultraviolet light


name: CT guided percutaneous fine needle aspiration biopsy of joint of left hip


name: CT of right tibia and fibula without contrast


name: Computed tomography of right tibia and fibula with contrast


name: Single photon emission computed tomography with computed tomography of liver


name: CT guided percutaneous biopsy of right lung


name: Physical medicine and rehabilitation service


name: CT guided percutaneous biopsy of left lung


name: Dual energy X-ray absorptiometry of axial and appendicular skeleton


name: CT of left tibia and fibula without contrast


name: Wound therapy oxygenator humidification pack


name: Intravenous access monitoring system, line-disconnection


name: Gastrointestinal telemetric monitoring system capsule, sterile


name: Pressure-regulated wound irrigation solution applicator


name: Thermo-mechanical skin surface treatment system handpiece


name: Ultrasound imaging system multi-transducer connection unit


name: Blood pressure cuff multichannel valve unit


name: CT of left tibia and fibula with contrast


name: Endoscopic optical coherence tomography system probe


name: Step down change in telehealth monitoring


name: Blood pressure cuff inflator, electronic


name: Thermo-mechanical skin surface treatment system


name: Endoscopic optical coherence tomography system


name: Gastrointestinal telemetric monitoring system receiver


name: Endoscopic-imaging ophthalmic solid-state laser system


name: Administration of Human papillomavirus 16 and 18 vaccine


name: Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for shingles


name: Fluoroscopy guided percutaneous transluminal angioplasty of spinal artery with contrast


name: Descemet's membrane automated endothelial keratoplasty


name: Descemet's membrane endothelial keratoplasty


name: Descemet's stripping automated endothelial keratoplasty


name: International Health Terminology Standards Development Organisation starter set module chinese


name: International Health Terminology Standards Development Organisation starter set module japanese


name: International Health Terminology Standards Development Organisation starter set module french


name: International Health Terminology Standards Development Organisation starter set module


name: International Health Terminology Standards Development Organisation starter set module german


name: French [International Organization for Standardization 639-1 code fr] language reference set


name: German [International Organization for Standardization 639-1 code de] language reference set


name: Japanese [International Organization for Standardization 639-1 code ja] language reference set


name: Chinese [International Organization for Standardization 639-1 code zh] language reference set


name: Fluoroscopy guided percutaneous needle biopsy of kidney


name: CT guided percutaneous drainage of lesion of pelvis


name: CT guided fine needle aspiration biopsy of abdomen


name: Therapeutic injection of left hip using fluoroscopic guidance


name: Screening mammography of bilateral breasts


name: Therapeutic injection of right shoulder using fluoroscopic guidance


name: Fluoroscopy guided therapeutic injection of right hip


name: Fine needle aspiration biopsy of pelvis using computed tomography guidance


name: Therapeutic injection of left shoulder using fluoroscopic guidance


name: Fluoroscopy guided injection of hip joint


name: Fluoroscopy guided injection of thrombin into pseudoaneurysm of extremity


name: Fine needle aspiration biopsy of chest using computed tomography guidance


name: CT guided percutaneous fine needle aspiration biopsy of joint of right hip


name: Fluoroscopy guided diagnostic lumbar puncture


name: Three dimensional obstetric ultrasonography in third trimester


name: Clinical immunology and allergy specialist


name: Thermo-mechanical skin surface treatment system handpiece tip


name: Provision of information about psychosis


name: Three dimensional obstetric ultrasonography


name: Hysteroscopic bipolar electrosurgical excision of uterine fibroid


name: Hysteroscopic electrosurgical diathermy system


name: General dentistry diagnostic reference set


name: International Health Terminology Standards Development Organisation odontogram module


name: Electromyographic endotracheal tube electrode


name: Magnetic resonance imaging interstitial thermal therapy system beam guide


name: Magnetic resonance imaging guided laser interstitial thermal therapy system beam guide driver


name: Magnetic resonance imaging guided laser interstitial thermal therapy system


name: Amputation of right leg through tibia and fibula


name: Amputation of right lower limb above knee


name: Amputation of left lower limb above knee


name: Dual energy computed tomography angiography of pulmonary artery with contrast


name: Dual energy computed tomography of neck, thorax, abdomen and pelvis


name: Dual energy computed tomography of abdomen and pelvis


name: Dual energy computed tomography of thorax, abdomen and pelvis


name: Dual energy computed tomography of thorax


name: Infiltration/extravasation monitoring system fiberoptic cable holder


name: Infiltration/extravasation monitoring system fiberoptic cable


name: Infiltration/extravasation monitoring system monitor


name: Bone-conduction hearing implant system sound processor


name: Invasive/noninvasive vascular ultrasound probe


name: Electric pad localized-body heating system


name: Antimicrobial skin friction/moisture control fabric


name: Protruding ear correction implant trial positioner


name: Hemodynamic-modulation vessel repair implant, intracranial/carotid


name: Amputation of left leg through tibia and fibula


name: Urodynamic manometric catheter, non-electronic


name: Prostate volume measurement system control unit


name: Prostate volume measurement system finger sleeve


name: Ear, nose and throat foreign body extractor


name: MRI of brain with arterial spin labeling


name: Fluoroscopic angiography of anterior tibial artery using contrast with insertion of drug eluting stent


name: Chronic kidney disease clinical management plan


name: Congestive heart failure clinical management plan


name: Myocardial infarction clinical management plan


name: Seizure disorder clinical management plan


name: Major depressive disorder clinical management plan


name: Ambulatory monitoring/recording system transceiver/cable


name: Stereotactic radiotherapy/magnetic resonance imaging system


name: Electromagnetic stimulation system application pad


name: Multi-agency case management review meeting


name: Fluoroscopy guided transcatheter mitral valve implantation


name: Registration for online access to local general practice service


name: Support for transition between environments


name: SCORE Index of Family Function and Change 15 Dimension 3 Disrupted Communication


name: SCORE Index of Family Function and Change 15 Dimension 2 Overwhelmed by Difficulties


name: SCORE Index of Family Function and Change 15 Dimension 1 Strengths and Adaptability


name: REEL-3 - Receptive Expressive Emergent Language Test Third Edition


name: Administration of booster dose of meningitis B vaccine


name: Administration of second dose of meningitis B vaccine


name: Administration of first dose of meningitis B vaccine


name: Assessment using Symbolic Play Test Second Edition


name: Nasal implant, synthetic polymer, bioabsorbable


name: RCBA-2 - Reading Comprehension Battery for Aphasia Second Edition


name: SCAN-3C Test for Auditory Processing Disorders in Children


name: Assessment using SCAN-3C Test for Auditory Processing Disorders in Children


name: Assessment using SCAN-C Test for Auditory Processing Disorders in Children


name: SCAN-C Test for Auditory Processing Disorders in Children


name: Argon-enhanced endoscopic electrosurgical electrode/submucosal lifting needle


name: Evaluation for workplace respirator wear


name: Video capsule endoscopy system capsule introducer


name: Advance care planning decisions shared with out of hours service


name: Patient advised medication may affect driving


name: High risk medication monitoring indicated


name: Restless legs syndrome vibratory counterstimulation system


name: Peripheral vascular electrosurgical catheter


name: Coronary angioplasty balloon catheter, drug-eluting


name: Hemodialysis water purification system washer/disinfector


name: Associating liver partition and portal vein ligation for staged hepatectomy


name: Cardiopulmonary bypass system filter, venous blood line


name: Implantable intraocular pressure monitoring system sensor injector


name: Implantable intraocular pressure monitoring system sensor insertion cartridge


name: Ultrasound endoscope balloon, synthetic polymer


name: Medication adherence telemetric monitoring system


name: SCORE Index of Family Function and Change 15


name: CT guided percutaneous fine needle aspiration biopsy of lung


name: Biological sterilization indicator reader


name: Medication adherence telemetric monitoring system transmitter


name: Tracheoesophageal speech valve irrigation device


name: Implantable intraocular pressure monitoring system monitor


name: Shared care prescribing protocol of drugs for dementia


name: Peripheral vascular electrocautery catheter


name: Assessment using REEL-3 (Receptive Expressive Emergent Language Scale - third edition)


name: REEL-2 (Receptive Expressive Emergent Language Scale - second edition)


name: Assessment using REEL-2 (Receptive Expressive Emergent Language Scale - second edition)


name: Assessment using Communication Activities of Daily Living Second Edition


name: Communication Activities of Daily Living


name: Abortion suction system manual aspirator


name: Provision of written information about diabetes and high hemoglobin A1c level


name: TACL-4 - Test for Auditory Comprehension of Language Fourth Edition


name: TACL-3 - Test for Auditory Comprehension of Language Third Edition


name: TAPS-3 - Test of Auditory Processing Skills Third Edition


name: Assessment using Hearing Handicap Inventory for the Elderly


name: Ocular volume ambulatory recording system recorder


name: Assessment using GFTA-3 (Goldman-Fristoe Test for Articulation 3)


name: Assessment using GFTA-2 (Goldman-Fristoe Test for Articulation 2)


name: Tracheoesophageal speech valve occluder, non-valved


name: Tracheoesophageal speech valve occluder, valved


name: Fluoroscopy guided percutaneous subintimal angioplasty with contrast


name: Balloon dilation of colon using fluoroscopic guidance


name: Ophthalmic solid-state laser system, photocoagulation


name: Enema using rectal route of administration


name: Wound therapy ultrasound system handpiece


name: Balloon dilation of stomach and duodenum using fluoroscopic guidance


name: Oblique occlusal plain X-ray of lateral mandibular region


name: CT of head, neck, abdomen and pelvis with contrast


name: Fluoroscopy guided insertion of bioabsorbable stent into airway


name: Ultrasonography guided fine needle aspiration biopsy of soft tissue


name: Assessment of chest drain swinging and bubbling


name: Fluoroscopy guided intravenous cardiac arrhythmia drug challenge test


name: Rancho Los Amigos Levels of Cognitive Functioning Scale


name: Assessment using Social Satisfaction Questionnaire


name: Assessment using Parenting Daily Hassles Scale


name: Occlusal plain X-ray of anterior mandibular region


name: Fluoroscopic angiography of anterior tibial artery using contrast with insertion of stent


name: True occlusal plain X-ray of mandibular region


name: Monitoring following treatment for cancer


name: Wound therapy ultrasound system generator


name: Wound therapy ultrasound system handpiece tip


name: Ocular volume ambulatory recording system sensor


name: Tracheoesophageal speech valve, indwelling, non-sterile


name: Implantable intraocular pressure monitoring system sensor


name: Goldman-Fristoe Test for Articulation Third Edition


name: Goldman-Fristoe Test for Articulation Second Edition


name: Referral for brief intervention for substance abuse


name: Fluoroscopy guided injection of botulinum toxin


name: Fluoroscopy guided removal of drain from chest


name: Fluoroscopy guided insertion of bioabsorbable venous stent with contrast


name: Fluoroscopy guided insertion of bioabsorbable arterial stent with contrast


name: Stereotactic plain X-ray guided vacuum assisted excision of lesion of breast


name: Site visit review of new housing development


name: Review of new housing development architectural plan


name: Ocular volume ambulatory recording system software


name: Syringe-loaded injector, manual, home-use


name: Implantable intraocular pressure monitoring system


name: Uniportal VATS - video assisted thoracoscopic surgery


name: Two stage orchidopexy using Fowler-Stephens technique


name: One stage orchidopexy using Fowler-Stephens technique


name: Fluoroscopy guided percutaneous liquid polymer embolization of arteriovenous malformation with contrast


name: Fluoroscopic angiography of posterior tibial artery using contrast with insertion of drug eluting stent


name: Fluoroscopic angiography of posterior tibial artery using contrast with insertion of stent


name: Fluoroscopic angiography of peroneal artery using contrast with insertion of stent


name: Opioid therapy for breathlessness management


name: Microsurgery of larynx using tungsten microelectrode


name: CT of chest, abdomen and pelvis without contrast


name: Percutaneous needle biopsy of transplanted pancreas


name: Fluoroscopic angiography of cervical branch of vertebral artery with contrast


name: Assessment using Elderly Assessment System


name: Assessment using Dizziness Handicap Inventory


name: Assessment using Children's Test of Nonword Repetition


name: Test of Language Development Fourth Edition


name: Assessment using Test of Language Development Fourth Edition


name: Phonological Awareness Test Second Edition


name: Assessment using Phonological Awareness Test Second Edition


name: Assessment using National Adult Reading Test


name: Assessment using Modified Word Learning Test


name: Illinois Test of Psycholinguistic Abilities Third Edition


name: Assessment using Illinois Test of Psycholinguistic Abilities Third Edition


name: Assessment using Denver Developmental Screening Test Second Edition


name: Assessment of pregnancy status prior to imaging


name: Assessment using Process of Recovery Questionnaire


name: Rivermead Activities of Daily Living Scale


name: Administration of typhoid VI capsular polysaccharide vaccine via intramuscular route


name: Administration of rabies vaccine via intramuscular route


name: Administration of inactivated poliomyelitis vaccine


name: Administration of live attenuated measles vaccine


name: Laparoscopic biopsy of transplanted kidney


name: Laparoscopic biopsy of transplanted pancreas


name: Fluoroscopy guided closure of arteriovenous fistula with insertion of stent with contrast


name: Assessment using Test of Pragmatic Language Skills Second Edition


name: Assessment using Stanford Binet Intelligence Scale fourth edition


name: CT of orbit and sella turcica without contrast


name: Tunneled catheter tip submitted as specimen


name: Assessment using Gray Silent Reading Test


name: Assessment using Frenchay Activities Index


name: Assessment using California Verbal Learning Test Second Edition


name: Assessment using California Verbal Learning Test Children's Version


name: Bedside Evaluation Screening Test Second Edition


name: Assessment using Bedside Evaluation Screening Test Second Edition


name: Interbody fusion of lumbar spine by anterior approach


name: Assessment using WAB (Western Aphasia Battery)


name: Neurological Disorders Depression Inventory in Epilepsy


name: Assessment using POEM (Patient-Oriented Eczema Measure)


name: Patient-Oriented Eczema Measure (assessment scale)


name: Assessment using Patient-Specific Functional Scale


name: STDAS-2 - Screening Test for Developmental Apraxia of Speech Second Edition


name: Assessment using New Salford Sentence Reading Test


name: Assessment using RCBA-2 (Reading Comprehension Battery for Aphasia Second Edition)


name: Assessment using TWF-3 (Test of Word Finding Third Edition)


name: DDST-II - Denver Developmental Screening Test Second Edition


name: Fluoroscopy guided percutaneous transluminal angioplasty of posterior tibial artery with contrast


name: Fluoroscopy guided percutaneous transluminal angioplasty of anterior tibial artery with contrast


name: World Health Organization Disability Assessment Schedule (WHODAS 2.0)


name: Assessment using Stanford Binet Intelligence Scale fifth edition


name: Assessment using Psycholinguistic Assessments of Language Processing in Aphasia


name: Assessment using CELF-5 (Clinical Evaluation of Language Fundamentals Fifth Edition)


name: CELF-5 - Clinical Evaluation of Language Fundamentals Fifth Edition


name: Fluoroscopic angiography of tibioperoneal trunk using contrast with insertion of stent


name: Recommendation regarding wheelchair requirement


name: Recommendation regarding seating requirement


name: Assessment using Wepman Auditory Discrimination Test Second Edition


name: Wepman Auditory Discrimination Test Second Edition


name: Fluoroscopy guided removal of gastrojejunostomy tube


name: Assessment of need for vehicle adaptation


name: Endoscopic electrosurgical electrode/submucosal lifting needle


name: IPOS (Integrated Palliative care Outcome Scale) Staff Version (1 week recall period)


name: Quantity of postpartum maternal blood loss


name: Therapeutic aspiration of cyst of breast


name: Assessment using SCAN-A Test for Auditory Processing Disorders in Adolescents and Adults


name: CT angiography of neck and chest and abdomen with contrast


name: Fluoroscopic angiography of tibioperoneal trunk using contrast with insertion of drug eluting stent


name: BAS-3 - British Ability Scales Third Edition


name: Assessment using BAS-3 (British Ability Scales Third Edition)


name: Assessment using TTFC-2 (Token Test for Children Second Edition)


name: TTFC-2 - Token Test for Children Second Edition


name: Assessment using PLS-5 (Preschool Language Scale - Fifth Edition)


name: PLS-5 - Preschool Language Scale Fifth Edition


name: Fluoroscopy guided insertion of arteriovenous shunt with contrast


name: Integrated Palliative care Outcome Scale 5 Patient Version (1 week recall period)


name: Integrated Palliative care Outcome Scale Patient Version (1 week recall period)


name: Integrated Palliative care Outcome Scale 5 Patient Version (3 day recall period)


name: Integrated Palliative care Outcome Scale Patient Version (3 day recall period)


name: Integrated Palliative care Outcome Scale Staff Version (3 day recall period)


name: Integrated Palliative care Outcome Scale 5 Staff Version (3 day recall period)


name: Fluoroscopy guided brush biopsy of bile duct


name: Integrated Palliative care Outcome Scale 5 Staff Version (1 week recall period)


name: Mitral annuloplasty perivalvular implant


name: CAARMS - Comprehensive Assessment of At-Risk Mental States


name: Assessment using Integrated Palliative care Outcome Scale Patient Version (1 week recall period)


name: Assessment using Integrated Palliative care Outcome Scale 5 Staff Version (3 day recall period)


name: Assessment using Integrated Palliative care Outcome Scale 5 Staff Version (1 week recall period)


name: Assessment using Integrated Palliative care Outcome Scale Patient Version (3 day recall period)


name: Assessment using Integrated Palliative care Outcome Scale 5 Patient Version (3 day recall period)


name: Assessment using Integrated Palliative care Outcome Scale Staff Version (1 week recall period)


name: Assessment using Integrated Palliative care Outcome Scale 5 Patient Version (1 week recall period)


name: Assessment using Integrated Palliative care Outcome Scale Staff Version (3 day recall period)


name: Assessment using CAARMS (Comprehensive Assessment of At-Risk Mental States)


name: OPHI-II (Occupational Performance History Interview II) Version 2.1 occupational competence scale


name: Assessment using Lower Extremity Functional Scale


name: Assessment using Neurological Disorders Depression Inventory in Epilepsy


name: Assessment of risk in community environment


name: Assessment of risk in educational environment


name: Fluoroscopy guided removal of intrauterine contraceptive device


name: Injection of steroid into trochanteric bursa


name: OPHI-II (Occupational Performance History Interview II) Version 2.1 occupational settings (environment) scale


name: Number of chronic care management minutes


name: Assessment using Child Session Rating Scale


name: RCADS (Revised Children's Anxiety and Depression Scale) generalized anxiety subscale


name: RCADS (Revised Children's Anxiety and Depression Scale) separation anxiety subscale


name: RCADS (Revised Children's Anxiety and Depression Scale) total anxiety and depression subscale


name: RCADS (Revised Children's Anxiety and Depression Scale) Obsessive Compulsive Disorder subscale


name: RCADS (Revised Children's Anxiety and Depression Scale) total anxiety subscale


name: Home-use transcranial magnetic stimulator


name: RCADS (Revised Children's Anxiety and Depression Scale) Major Depressive Disorder subscale


name: RCADS - Revised Children's Anxiety and Depression Scale


name: Assessment using Zung self rating depression scale


name: RCADS-P (Revised Children's Anxiety and Depression Scale Parent Version) total anxiety and depression subscale


name: RCADS (Revised Children's Anxiety and Depression Scale) Parent Version Major Depressive Disorder subscale


name: RCADS-P (Revised Children's Anxiety and Depression Scale Parent Version) generalized anxiety subscale


name: RCADS-P (Revised Children's Anxiety and Depression Scale Parent Version) separation anxiety subscale


name: RCADS-P (Revised Children's Anxiety and Depression Scale Parent Version) Obsessive Compulsive Disorder subscale


name: RCADS-P (Revised Children's Anxiety and Depression Scale Parent Version) Panic Disorder subscale


name: RCADS-P - Revised Children's Anxiety and Depression Scale Parent Version


name: CADS (Revised Children's Anxiety and Depression Scale) social phobia subscale


name: RCADS (Revised Children's Anxiety and Depression Scale) Panic Disorder subscale


name: Plain X-ray of chest, apical and lordotic views


name: MR venography of intracranial veins without contrast


name: Privacy policy acknowledgment of electronic data usage


name: MRI of thoracic spine and lumbar spine without contrast


name: OPHI-II (Occupational Performance History Interview II) Version 2.1 occupational identity scale


name: MRI of sacrococcygeal region of spine without contrast


name: MRI of paranasal sinuses without contrast


name: MRI of lower limb joint without contrast


name: MRI of cervical, thoracic, and lumbar spine with contrast


name: MRI of cerebrospinal fluid flow without contrast


name: MRI of brain and internal auditory canal without contrast


name: MRI of brain and facial bones without contrast


name: MRI of brain and cervical spinal cord without contrast


name: MRI of brain and brain stem without contrast


name: MRI of brain and brain stem with contrast


name: MRI of bilateral hip joints without contrast


name: MRI of abdomen and pelvis without contrast


name: MR arthrography of upper limb without contrast


name: Magnetic resonance angiography of spine without contrast


name: Magnetic resonance angiography of neck without contrast


name: Magnetic resonance angiography of head without contrast


name: Magnetic resonance angiography of head and brain without contrast


name: Magnetic resonance angiography of chest, abdomen and pelvis without contrast


name: Plain X-ray of gastrointestinal tract with marker capsule for transit study


name: Magnetic resonance angiography of brain and neck without contrast


name: Magnetic resonance angiography of abdomen and pelvis without contrast


name: Low dose computed tomography of chest without contrast


name: CT of temporomandibular joint without contrast


name: CT of sternoclavicular joint without contrast


name: CT of sacrum and coccyx without contrast


name: CT of orbit and sella turcica with contrast


name: CT of neck, chest, abdomen and pelvis without contrast


name: BBCS-3:R - Bracken Basic Concept Scale Third Edition: Receptive


name: CT of internal auditory structure without contrast


name: CT of chest and abdomen without contrast


name: CT angiography of pulmonary artery with contrast


name: Assessment using Diagnostic Interview for Children and Adolescents


name: Assessment using Assessment of Comprehension and Expression 6-11


name: Assessment using Children's Communication Checklist Second Edition


name: Administration of meningitis polysaccharide vaccine


name: Assessment using Crichton Vocabulary Scale


name: Assessment using Lysholm Knee Scoring Scale


name: Assessment using Rivermead Behavioral Memory Test Third Edition


name: Assessment using Rivermead Behavioral Memory Test for Children


name: Doppler ultrasonography of intrathoracic vascular structure


name: Assessment using RCADS-P (Revised Children's Anxiety and Depression Scale Parent Version)


name: Fluoroscopy guided percutaneous transluminal angioplasty of banding of pulmonary artery with contrast


name: Assessment using Goodenough Draw A Man Test


name: Assessment using Amyotrophic Lateral Sclerosis Functional Rating Scale Revised


name: STOPP - Screening Tool of Older Person's Prescriptions


name: Assessment using STOPP (Screening Tool of Older Person's Prescriptions)


name: Mothers' Object Relations Scale - Short Form - Invasiveness Subscale


name: Mothers' Object Relations Scale - Short Form - Warmth Subscale


name: Recommendation regarding personal motor vehicle requirement


name: Mothers' Object Relations Scale - Short Form


name: Assessment using Mothers' Object Relations Scale Short Form


name: CT angiography of chest and abdomen with contrast


name: Assessment using Clinical Outcomes in Routine Evaluation Learning Disabilities


name: Transcranial electrical stimulation system, continuous-current


name: Suction system filter, tissue, non-sterile


name: Assessment using Test of Minimal Articulation Competence


name: Extracorporeal cardiopulmonary support system circuit


name: Orthodontic elastomeric appliance pusher


name: Percutaneous electrosurgical probe, brain-ablation


name: Clinical Institute Withdrawal Assessment for Benzodiazepines scale


name: Dyadic Assessment of Naturalistic Caregiver child Experiences


name: Positron emission tomography with computed tomography of brain using flutemetamol (18-F)


name: Assessment using Clinical Institute Withdrawal Assessment for Benzodiazepines scale


name: Assessment using Screening Tool to Alert doctors to Right Treatment


name: RCADS-P (Revised Children's Anxiety and Depression Scale Parent Version) social phobia subscale


name: Screening Tool to Alert doctors to Right Treatment


name: Assessment using Dyadic Assessment of Naturalistic Caregiver child Experiences


name: CT guided insertion of fiducial marker into kidney


name: Administration of prophylactic bendroflumethiazide


name: Administration of prophylactic metolazone


name: Administration of prophylactic eplerenone


name: Assessment using PLS-4 (Preschool Language Scale Fourth Edition)


name: PLS-4 - Preschool Language Scale Fourth Edition


name: Assessment using BLADES (Bristol Language Assessment Scale)


name: SPECT CT of kidney using dimercaptosuccinic acid with contrast


name: RCADS-P (Revised Children's Anxiety and Depression Scale Parent Version) total anxiety subscale


name: X-ray tomography of internal auditory canal


name: X-ray tomography of temporomandibular joint


name: Fluoroscopy guided percutaneous transluminal angioplasty of trunk of pulmonary artery with contrast


name: Antenatal screening for fetal growth retardation


name: Gastroesophageal pH/impedance catheter, non-sterile


name: Impedance pneumography recording/analysis system


name: Fluoroscopy guided percutaneous transluminal angioplasty of banding of trunk of pulmonary artery with contrast


name: Cough long-term ambulatory recording system


name: Oxygen therapy compliance long-term ambulatory recorder


name: Enteral feeding/medication connector, sterile


name: Gastrointestinal manometric catheter, electronic


name: Functional Communication Profile Revised


name: Ultrasonography guided steroid injection


name: Assessment using Macmillan Readers Level Test


name: Assessment using Renfrew Word Finding Vocabulary Test


name: Assessment using European Union Scale for Peak Expiratory Flow Rate for adults


name: Assessment using Eysenck Personality Questionnaire


name: Assessment using DIALOG patient rated outcome measure


name: Focused transthoracic echocardiography in intensive care


name: Talking Sense Talking Blood Pressure Monitor System (XL Cuff)


name: Talking Sense Talking Blood Pressure Monitor System


name: Health Sense Upper-Arm Blood Pressure Monitor System (XL Cuff)


name: Health Sense Upper-Arm Blood Pressure Monitor System


name: Easy Comfort 1ML 30G 5/16 inc Insulin Syringe


name: Easy Comfort 1ML 30G 1/2 inch Insulin Syringe


name: Easy Comfort 1/2ML 31G 5/16 inch Insulin Syringe


name: Easy Comfort 1/2ML 30G 5/16 inch Insulin Syringe


name: Easy Comfort 1/2ML 30G 1/2 inch Insulin Syringe


name: GNP Home Lice, Bed Bug & Dust Mite Spray


name: Tissue Human Implantation Sheet [NUSHIELD]


name: Zinc Oxide;Cleanser;Lotion, Multi Ingredient;Powder, Multi Ingredient;Shampoo, Multi Ingredient 13%; NA; NA; NA; NA Topical application Kit


name: Insulin Human Inhaled;Insulin Human Inhaled;Insulin Human Inhaled 4 U; 8 U; 12 U Inhalation Aerosol Powder


name: Dextromethorphan Hydrobromide/Phenylephrine Hydrochloride;Diphenhydramine Hydrochloride/Phenylephrine Hydrochloride 5 MG/5 ML-2.5 MG/5 ML; 6.25 MG/5 ML-2.5 MG/5 ML Oral Solution


name: TITANIUM DIOXIDE 60 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL CREAM [Tropical Sands SPF-30 Broad Spectrum Sunscreen]


name: Tofacitinib Citrate 24.75 g in 25 g NOT APPLICABLE POWDER [X]


name: TITANIUM DIOXIDE 60 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL CREAM [Tropical Sands, SPF-50 Broad Spectrum Sunscreen]


name: TITANIUM DIOXIDE 60 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL CREAM [Tropical Sands SPF-30 Broad Spectrum Sunscreen (Coconut)]


name: TITANIUM DIOXIDE 60 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL CREAM [Coral Safe SPF-30 Broad Spectrum Sunscreen]


name: Titanium Dioxide 110 mg in 1 mL TOPICAL LOTION [La Roche Posay Laboratoire Dermatologique Anthelios 50 Tinted Mineral Face Broad Spectrum SPF 50 Sunscreen]


name: Homosalate 6.65 g in 70 mL / Octocrylene 3.50 g in 70 mL / Octisalate 3.15 g in 70 mL / Avobenzone 2.10 g in 70 mL TOPICAL CREAM [LEADERS SUNBUDDY DAILY MOISTURE SUNSCREEN]


name: OCTINOXATE 7.5 g in 100 g / TITANIUM DIOXIDE 5 g in 100 g / ZINC OXIDE 0.99 g in 100 g TOPICAL LOTION


name: OCTINOXATE 3 g in 100 mL / ZINC OXIDE 6.8 g in 100 mL TOPICAL CREAM [Cappuccino Radiance Foundation Broad Spectrum SPF 20 - Tawny JAFRA]


name: Octinoxate 2.1 g in 30 mL / Homosalate 1.8 g in 30 mL / Octisalate 1.35 g in 30 mL TOPICAL OIL [TONYMOLY BCDATION MULTI USE SUN]


name: {41 (dexamethasone 1.5 MG Oral Tablet) } Pack


name: {27 (dexamethasone 1.5 MG Oral Tablet) } Pack


name: OCTINOXATE 7.5 g in 100 mL / OCTOCRYLENE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 2.5 g in 100 mL TOPICAL SPRAY [bu SPF 30 Broad Spectrum Alcohol-Free Performance Sunscreen - Natural Citrus Scent]


name: ZINC OXIDE 20 g in 100 g TOPICAL GEL [Silagen]


name: ZINC OXIDE 20 g in 100 g TOPICAL GEL [NewGel Plus SPF]


name: {21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Chewable Tablet) / 7 (ferrous fumarate 75 MG Chewable Tablet) } Pack [Nexesta Fe 28 Day]


name: TITANIUM DIOXIDE .25803 g in 1 mL / ZINC OXIDE .31416 g in 1 mL TOPICAL LOTION [PRO TRIPLE PROTECTION FACTOR BROAD SPECTRUM SPF 50 SUNSCREEN]


name: Esika PRO HD LONGWEAR LONG-LASTING HIGH-DEFINITION COLOR SPF 20 KIT


name: Octinoxate 0.068 g in 1 g TOPICAL LIPSTICK [Esika PRO HD LONGWEAR LONG-LASTING HIGH-DEFINITION COLOR SPF 20 CORAL ENSUENO - RED]


name: OCTINOXATE 1.065 g in 14.2 g / OCTISALATE .71 g in 14.2 g / AVOBENZONE .426 g in 14.2 g / ZINC OXIDE .142 g in 14.2 g TOPICAL LOTION [PRO TRIPLE PROTECTION FACTOR LIP BALM BROAD SPECTRUM SPF 30 SUNSCREEN]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 45 mg in 1 g / OCTOCRYLENE 40 mg in 1 g / OXYBENZONE 60 mg in 1 g TOPICAL LOTION [Copperstone Water Babies Pure and Simple Whipped Sunscreen Broad Spectrum SPF 50 SPF 50]


name: ZINC OXIDE 95 mg in 1 mL TOPICAL CREAM [Dr Mercola Broad Spectrum SPF15]


name: ZINC OXIDE 200 mg in 1 mL TOPICAL CREAM [Dr. Mercola Broad Spectrum]


name: TITANIUM DIOXIDE 60 mg in 1 mL / ZINC OXIDE 225 mg in 1 mL TOPICAL CREAM [Dr. Mercola Broad Spectrum]


name: OCTINOXATE 75 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTISALATE 30 mg in 1 mL TOPICAL CREAM [LBri Pure nNatural Oil Free Moisturizer]


name: OCTISALATE 3.2 g in 100 g / OCTOCRYLENE 2.4 g in 100 g / HOMOSALATE 4.5 g in 100 g / AVOBENZONE 3 g in 100 g TOPICAL OIL [Banana Boat]


name: Bisacodyl;Hydrocortisone Acetate/Lidocaine Hydrochloride;Polyethylene Glycol 3350 5 MG; 0.5%-3%; 17 GM/1 DOSE Multiple Routes Kit [POLY-PREP]


name: Titanium Dioxide 212 mg in 1 g / Zinc Oxide 120 mg in 1 g TOPICAL POWDER [Mineral Corrector Palette SPF 20 Sunscreen]


name: TITANIUM DIOXIDE 49.39 mg in 1 mL / ZINC OXIDE 47.145 mg in 1 mL TOPICAL LOTION [CVS Health 60 Plus Sensitive Skin Sun]


name: Lidocaine/Prilocaine;Menthol/Methyl Salicylate 2.5%-2.5%; 10%-30% Multiple Routes Cream [PAINGO KFT]


name: Octinoxate 0.07 g in 1 mL / Zinc Oxide 0.072 g in 1 mL TOPICAL LIQUID [LBEL CONCENTRE TOTAL BASE SERUM ULTRA-FLUID FOUNDATION SPF 25 CLAIRE 1 - BEIGE]


name: Avobenzone 30 mg in 1 g / Octisalate 50 mg in 1 g / Octocrylene 70 mg in 1 g TOPICAL CREAM [Lancome Paris Renergie Lift MultiAction Sunscreen Broad Spectrum SPF 15 Lift and Firming Face and Neck All Skin Types]


name: GLYCERIN 5 mg in 1 mL TOPICAL CREAM [Vitalizing Energizing Nourishing Cream]


name: GLYCERIN 3 mg in 1 mL / DIMETHICONE 0.4 mg in 1 mL TOPICAL CREAM [Vitalizing Energizing Moisturizing Cream]


name: DIMETHICONE 0.4 mg in 1 mL / GLYCERIN 3 mg in 1 mL TOPICAL CREAM [Vitalizing Energizing Serum]


name: urinary bag/catheter 14 Fr-16" MISCELL COMBINATION PACKAGE (EA)


name: Survival Motor Neuron-2-directed RNA Interaction


name: Platelet-derived Growth Factor Receptor alpha Antagonist


name: gentamicin / hydrocortisone / miconazole


name: HEAT & MOISTURE EXCHANGER,VENTLAB #FH603011


name: DRESSING,ALLEVYN LIFE FOAM 8 1/4IN X 8 1/4IN


name: DRESSING,ALLEVYN LIFE FOAM 4IN X 4IN U#66021067


name: CATHETER,FOLEY COUDE 20FR 30ML BARD#0100L-20


name: PAR (protease-activated receptor)-3 receptor, human


name: TMEM126B, GLY212VAL (dbSNP SCV000280579)


name: TRMT10C, THR272ALA (dbSNP SCV000264780.0)


name: TRMT10C, ARG181LEU (dbSNP SCV000264779.0)


name: PEX26, 1-BP INS, 35C AND 147-BP DEL, NT668


name: ADGRG1, 15-BP DEL, 144 BP UPSTREAM OF EXON 1M


name: F8, IVS6DS, A-G, +3, 186-BP DEL, EX5-6 DEL


name: HBB, 4-BP DEL/1-BP INS, CODONS 138/139, GCTA/T


name: GNAS, METHYLATION CHANGES, PATERNAL EPIGENOTYPE


name: Supplies for external insulin infusion pump, syringe type cartridge, sterile, each


name: Medicaid certified community behavioral health clinic services, per month


name: Medicaid certified community behavioral health clinic services, per diem


name: Comprehensive management and care coordination for advanced illness, per calendar month


name: Colonoscopy consultation performed prior to a screening colonoscopy procedure


name: Ankle orthosis, ankle gauntlet or similar, with or without joints, custom fabricated


name: Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf


name: Endometrial sampling or hysteroscopy with biopsy and results not documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation


name: Endometrial sampling or hysteroscopy with biopsy and results documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation


name: Patients who had an endometrial ablation procedure during the 12 months prior to the index date (exclusive of the index date)


name: Patients who did not receive cervical cytology or an hpv test


name: Patients who received cervical cytology or an hpv test


name: Pathologists/dermatopathologists providing a second opinion on a biopsy


name: Patients who have a diagnosis of rhabdomyolysis at any time during the performance period


name: Patients who are breastfeeding at any time during the performance period


name: Hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment


name: Patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment


name: Surgical procedures that included the use of silicone oil (G9756)


name: Patients who had documentation of use of anticoagulant medications overlapping the measurement year


name: Documentation stating the patient has had a diagnosis of bipolar disorder


name: Documentation of medical reason(s) for prescribing or dispensing antibiotic (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis/ mastoiditis/bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia, gonococcal infections/venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis/uti, acne, hiv disease/asymptomatic hiv, cystic fibrosis, disorders of the immune system, malignancy neoplasms, chronic bronchitis, emphysema, bronchiectasis, extrinsic allergic alveolitis, chronic airway obstruction, chronic obstructive asthma, pneumoconiosis and other lung disease due to external agents, other diseases of the respiratory system, and tuberculosis


name: Patients with a diagnosis or past history of total colectomy or colorectal cancer


name: Documentation of system reason(s) for not prescribing a long-acting inhaled bronchodilator (e.g., cost of treatment or lack of insurance)


name: Documentation of medical reason(s) for not prescribing a long-acting inhaled bronchodilator (e.g., patient intolerance or history of side effects)


name: Long-acting inhaled bronchodilator prescribed


name: Physician service or other qualified health care professional for the evaluation and management of a beneficiary's acute change in condition in a nursing facility. this service is for a demonstration project


name: This code is for the onsite acute care treatment of a nursing facility resident for a uti; may only be billed once per day per beneficiary


name: This code is for the onsite acute care treatment a nursing facility resident with a skin infection; may only be billed once per day per beneficiary


name: This code is for onsite acute care treatment of a resident with copd or asthma; may only be billed once per day per beneficiary


name: This code is for onsite acute care treatment of a nursing facility resident with chf; may only be billed once per day per beneficiary


name: This code is for onsite acute care treatment of a nursing facility resident with pneumonia; may only be billed once per day per beneficiary


name: Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved coms innovation center demonstration project, which requires at least 2 of the following 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 40 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology


name: Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: a detailed history; a detailed examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 25 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology


name: Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 15 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology


name: Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology


name: Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 60 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology


name: Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 45 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology


name: Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a detailed history; a detailed examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate severity. typically, 30 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology


name: Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 20 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology


name: Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a problem focused history; a problem focused examination; and straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology


name: Telehealth consultation, critical care, subsequent, physicians typically spend 50 minutes communicating with the patient and providers via telehealth


name: Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth


name: Care management services for behavioral health conditions, at least 20 minutes of clinical staff time, directed by a physician or other qualified health care professional, per calendar month, with the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales, behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes, facilitating and coordinating treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric consultation, and continuity of care with a designated member of the care team.


name: Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service)


name: Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.


name: Initial psychiatric collaborative care management, first 70 minutes in the first calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: outreach to and engagement in treatment of a patient directed by the treating physician or other qualified health care professional, initial assessment of the patient, including administration of validated rating scales, with the development of an individualized treatment plan, review by the psychiatric consultant with modifications of the plan if recommended, entering patient in a registry and tracking patient follow-up and progress using the registry, with appropriate documentation, and participation in weekly caseload consultation with the psychiatric consultant, and provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies.


name: Resource-intensive services for patients for whom the use of specialized mobility-assistive technology (such as adjustable height chairs or tables, patient lift, and adjustable padded leg supports) is medically necessary and used during the provision of an office/outpatient, evaluation and management visit (list separately in addition to primary service)


name: Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)


name: Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result


name: Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion


name: Skilled services of a licensed practical nurse (lpn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes


name: Skilled services of a registered nurse (rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes


name: Skilled services of a licensed practical nurse (lpn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)


name: Skilled services of a registered nurse (rn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)


name: Dialysis procedure with single evaluation by a physician or other qualified health care professional for acute kidney injury without esrd


name: Dialysis procedure at a medicare certified esrd facility for acute kidney injury without esrd


name: Face-to-face home health nursing visit by a rural health clinic (rhc) or federally qualified health center (fqhc) in an area with a shortage of home health agencies; (services limited to rn or lpn only)


name: Implantable/insertable device, not otherwise classified


name: Hygienic item or device, disposable or non-disposable, any type, each


name: Belt, strap, sleeve, garment, or covering, any type


name: Supplies for maintenance of insulin infusion catheter, per week


name: Non-excepted service provided at an off-campus, outpatient, provider-based department of a hospital


name: Ventricular Assist Devices (CMS Temporary Codes)


name: Chemotherapy Administration(CMS Temporary Codes)


name: Prosthetic Implants - Miscellaneous Orthotic or Prosthetic Component or Accessory


name: Additional Incontinence and Ostomy supplies


name: Evaluation of adverse drug event history


name: Evaluation of medication-related care plan


name: Documentation of medication-related goals


name: Emergency medical treatment and active labor act medical screening examination


name: Recommendation to change medication to lower cost therapeutic equivalent


name: Recommendation to monitor patient satisfaction


name: Recommendation to monitor medication adherence


name: Education about medication intake during lactation


name: Education about timing of medication administration


name: Education about genetic predisposition to disease


name: Education about point of care laboratory measurement device


name: Education about safe disposal of medication


name: Referral for high risk medication monitoring


name: Targeted medication therapy review without patient present


name: Development of medication-related action plan with patient


name: Development of medication-related goals with patient


name: Medication care plan discussed with primary care provider


name: Emergency department healthcare professional


name: Education about automatic medication dispensing system


name: Education about elastomeric infusion pump


name: Revision of reconstruction of head of left radius


name: Revision of reconstruction of head of right radius


name: Gender, age, AFP-L3, α fetoprotein and des-carboxy-prothrombin score (assessment scale)


name: hemiarthroplasty of head of right humerus


name: Counseling about diagnostic imaging findings


name: Excision of Soft Tissue Lesions - dental


name: Special stains for microorganisms - dental


name: {6 (0.4 ML adalimumab 100 MG/ML Auto-Injector [Humira]) } Pack [Humira Pen 40 MG/0.4 ML Starter Pack - Crohn's Disease]


name: {4 (0.4 ML adalimumab 100 MG/ML Auto-Injector [Humira]) } Pack [Humira Pen 40 MG/0.4 ML Starter Pack - Psoriasis]


name: {3 (0.8 ML adalimumab 100 MG/ML Prefilled Syringe [Humira]) } Pack [Humira Prefilled Syringe 80 MG/0.8 ML Starter Pack - Pediatric Crohn's Disease]


name: nystatin 50000000 units compounding powder


name: CDISC SDTM Device-In-Use Response Terminology


name: Relief Redness Reliever and Lubricant Eye Drops


name: benzoyl peroxide 65 % to 82 % MISCELL POWDER (GRAM)


name: Endoscopic sphincterotomy and papillotomy


name: BENZOCAINE 5 g in 100 mL TOPICAL GEL [Pleasure Balm Kama Sutra]


name: Thuja occidentalis / arbor vitae homeopathic preparation


name: desonide, micronized MISCELL POWDER (GRAM)


name: Local anesthesia in conjunction with dental operative or surgical procedures


name: pyrithione zinc 48 % MISCELL LIQUID (GRAM)


name: S100 Calcium Binding Protein A7 Measurement


name: Bupivacaine Hydrochloride Monohydrate, compounding powder


name: deoxycholic acid 98 % MISCELL POWDER (GRAM)


name: Dexamethasone 1.5 MG Oral Tablet includes 7, 11, 21, 35 & 51 Day Packs


name: aldosterone 97.5 % MISCELL POWDER (GRAM)


name: beta 1,3 glucan 91 % MISCELL POWDER (GRAM)


name: amifampridine 98 % MISCELL POWDER (GRAM)


name: hyaluronate sodium 94 % MISCELL POWDER (GRAM)


name: resveratrol greater than 98 % MISCELL POWDER (GRAM)


name: zinc chloride 100 % MISCELL GRANULES (GRAM)


name: estradiol hemihydrate, micronized 100 % MISCELL POWDER (GRAM)


name: GLYCERIN 10 g in 50 mL TOPICAL CREAM [Ato Pollen]


name: Aloe Vera Topical application Solution [COATS ALOE LIQUID]


name: Bupivacaine Hydrochloride;Methylprednisolone Acetate;Povidone Iodine 0.5%; 40 MG/1 ML; 10% Multiple Routes Kit


name: VOPAC GB Cream Compounding Preparation Kit


name: Humira 100 MG/ML 0.8 ML Prefilled Syringe and Humira Prefilled Syringe 80 MG/0.8 ML Starter Pack - Pediatric Crohn's Disease


name: DIMETHICONE 5%/TRIAMCINOLONE ACETONIDE 0.1% CREAM,KIT


name: CAPSAICIN 0.025% CREAM/DICLOFENAC NA 75MGX60 TAB,EC KIT


name: Active-Prep III 10%-20%-2% Kit for Compounding


name: AVOBENZONE 3 g in 100 mL / OCTINOXATE 5 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 2.4 g in 100 mL / OXYBENZONE 5 g in 100 mL TOPICAL CREAM [Active Radiance Day Moisture SPF 30]


name: OCTISALATE 3 g in 100 mL / ZINC OXIDE 6.8 g in 100 mL TOPICAL CREAM [Long Wear Makeup Broad Spectrum SPF 20 Nude Jafra]


name: TITANIUM DIOXIDE 60 mg in 1 g / ZINC OXIDE 60 mg in 1 g TOPICAL LOTION [Sunstation All-Natural SPF 30 Sunscreen]


name: ZINC OXIDE 22 g in 100 g TOPICAL STICK [TRADER JOE S MINERAL SUNSCREEN]


name: OCTINOXATE .07575 g in 1 mL / OXYBENZONE .06 g in 1 mL / OCTISALATE .0505 g in 1 mL / OCTOCRYLENE .0525 g in 1 mL / AVOBENZONE .03237 g in 1 mL TOPICAL LOTION [PRO TRIPLE PROTECTION FACTOR FACE AND BODY BROAD SPECTRUM SPF 30 SUNSCREEN]


name: BUSERELIN ACETATE .99 g in 1 g NOT APPLICABLE POWDER [AX Pharmaceutical]


name: Guanabenz Acetate 4.95 g in 5 g NOT APPLICABLE POWDER [AX Pharmaceutical]


name: ORLISTAT 495 g in 500 g NOT APPLICABLE POWDER [X]


name: ZINC OXIDE 8.82 g in 90 mL TOPICAL LIQUID [Stout Daily SPF for Men]


name: BENAZEPRIL HYDROCHLORIDE 49.5 g in 50 g NOT APPLICABLE POWDER [X]


name: GLYCERIN 1.12 mg in 1 mL / DIMETHICONE 0.75 mg in 1 mL TOPICAL CREAM [Shine Control Matte Effect Cream]


name: GLYCERIN 5 mg in 1 mL TOPICAL GEL [Shine Control Sebum Regulating Gel]


name: AVOBENZONE 25 mg in 1 mL / OCTINOXATE 30 mg in 1 mL / OCTISALATE 30 mg in 1 mL / TITANIUM DIOXIDE 12.5 mg in 1 mL TOPICAL LOTION [DermacinRx Skin Moisturizing Ultra SPF 50 Sunscreen]


name: CATHETER FOLEY 3-WAY 18FR 5ML BARD #0119L18


name: CATHETER,FOLEY 16FR 5/10ML POIESIS #10016


name: CATHETER,FOLEY 2-WAY SILICONE COUDE 16FR 15ML COLOPLAST#AA6316


name: CATHETER,FOLEY SILICONE 24FR 10ML M#DYND11506


name: CATHETER,INTERMITTENT 14FR FEMALE COLOPLAST #28814


name: CATHETER,INTERMITTENT,MAGIC3 14FR ROCHESTER #53514


name: CENTRAL LINE DRESSING CHANGE KIT,DEROYAL #47-324


name: DRESSING,MEDLINE ISLAND 2IN X 2IN #MSC3222


name: DRESSING,PURACOL 2IN X 2IN MEDLINE #MSC8522


name: DRESSING,PURACOL 4IN X 4.25IN MEDLINE#MSC8544


name: DRESSING,THERABOND 3D 6IN X 96IN A#3DAW696


name: TRACH ANTI-DISCONNECT DEVICE,SHILEY #ADD


name: Niacinamide 2.4 g in 120 mL / PANTHENOL 0.12 g in 120 mL / ADENOSINE 0.04 g in 120 mL TOPICAL LIQUID [VITA VOLU 101 ESSENCE]


name: Niacinamide 3.6 g in 180 mL / Adenosine 0.07 g in 180 mL TOPICAL LIQUID [VITA VOLU VOLUME BOOSTER]


name: GLYCERIN 6.25 mg in 1 mL / DIMETHICONE 2.18 mg in 1 mL TOPICAL CREAM [Shine Control Moisturizing Matte Effect Cream]


name: {6 (0.4 ML adalimumab 100 MG/ML Auto-Injector) } Pack


name: {4 (0.4 ML adalimumab 100 MG/ML Auto-Injector) } Pack


name: {3 (0.8 ML adalimumab 100 MG/ML Prefilled Syringe) } Pack


name: Leader PulmoNeb LT Compressor Nebulizer System


name: RITE AID One Daily Prenatal with DHA Combo Pack


name: {24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Oral Tablet) } Pack [Mibelas 24 Fe Chewable 28 Day]


name: compression panty, large-extra large MISCELL EACH


name: compression panty, small-medium MISCELL EACH


name: silicone adhesive 10 cm X 12 cm TOPICAL SHEET (EA)


name: subcutaneous bolus insulin patch pump, 200 unit, disposable 2 unit MISCELL EACH


name: subcut bolus insulin patch pump,200 unit,disposabl


name: Homosalate 40 mg in 1 mL / Octisalate 40 mg in 1 mL / Avobenzone 30 mg in 1 mL / Oxybenzone 30 mg in 1 mL / Octocrylene 20 mg in 1 mL TOPICAL LIQUID [Skin Pharmacy Advanced Sun Therapy Broad Spectrum SPF 30 Sun]


name: TITANIUM DIOXIDE 129.3 mg in 1 mL / ZINC OXIDE 108.9 mg in 1 mL TOPICAL CREAM [Tinted Sunscreen Cream SPF 30 4-Deep Amber]


name: homosalate 100 mg in 1 mL / octisalate 50 mg in 1 mL / avobenzone 30 mg in 1 mL / octocrylene 20 mg in 1 mL / oxybenzone 50 mg in 1 mL TOPICAL LOTION [SkinPharmacy Advanced Anti-Aging Therapy Glycolic Day Moisturizer SPF 30]


name: TRILOSTANE 9.9 kg in 10 kg NOT APPLICABLE POWDER [X]


name: {21 (ribociclib 200 MG Oral Tablet) } Pack


name: {21 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali 200 MG Daily Dose Carton]


name: {42 (ribociclib 200 MG Oral Tablet) } Pack


name: {42 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali 400 MG Daily Dose Carton]


name: {63 (ribociclib 200 MG Oral Tablet) } Pack


name: {63 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali 600 MG Daily Dose Carton]


name: Levetiracetam 24.75 kg in 25 kg NOT APPLICABLE POWDER [X]


name: MELOXICAM .99 kg in 1 kg NOT APPLICABLE POWDER [X]


name: OCTOCRYLENE 45 mg in 1 mL / OCTISALATE 50 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OXYBENZONE 40 mg in 1 mL TOPICAL LOTION [CVS Health SPF 70 Beach Guard Sun]


name: ZINC OXIDE 10 g in 100 mL / OCTINOXATE 7.5 g in 100 mL TOPICAL CREAM [Sunscreen Broad Spectrum SPF 50 Vi Aesthetics]


name: octinoxate 60 mg in 1 g / octisalate 50 mg in 1 g / oxybenzone 40 mg in 1 g / titanium dioxide 39 mg in 1 g / zinc oxide 20 mg in 1 g TOPICAL LOTION [Age Renewal Firming and Hydrating Moisturizer SPF 30]


name: Dimethicone;Triamcinolone Acetonide 5%; 0.1% Topical application Kit


name: 1,1,1,3,3-Pentafluoropropane/Norflurane;Dexamethasone Sodium Phosphate;Isopropyl Alcohol 10 MG/1 ML; 70% Multiple Routes Kit


name: Diphenhydramine Hydrochloride;Prednisone 50 MG; 50 MG Oral Kit


name: TheraNatal Lactation Complete, Prenatal Multivitamins with Folic Acid 0.4 mg oral kit


name: {1 (22 ML) (benzoyl peroxide 25 MG/ML Topical Lotion) / 1 (12 ML) (benzoyl peroxide 50 MG/ML Topical Lotion) / 1 (118 ML) (salicylic acid 20 MG/ML Medicated Liquid Soap) } Pack


name: {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [Fayosim 91 Day]


name: Penicillin G Potassium .99 kg in 1 kg NOT APPLICABLE POWDER [X]


name: MELENGESTROL ACETATE 1 kg in 1 kg POWDER


name: GLYCERIN 8.6 g in 200 mL TOPICAL CREAM [NATURAL SAVON 4IN1 PLUS]


name: GLYCERIN 8.28 g in 180 mL TOPICAL LOTION [VITALISING TONIC]


name: GLYCERIN 1.97 g in 30 mL TOPICAL CREAM [NYMPHSYN INTENSIVE SERUM]


name: GLYCERIN 1.4 g in 50 mL TOPICAL CREAM [NYMPHSYN FACE MASK]


name: GLYCERIN 0.29 g in 30 mL TOPICAL CREAM [NYMPHSYN EYE]


name: DIMETHICONE 7.06 g in 50 mL TOPICAL CREAM [OXY STEM M]


name: GLYCERIN 0.02 g in 2 mL TOPICAL LIQUID [G3S AMPOULE]


name: GLYCERIN 0.04 g in 5 mL TOPICAL LIQUID [ULTRA REJUVE 7S AMPOULE]


name: GLYCERIN 0.29 g in 5 mL TOPICAL LIQUID [PEPTICOL 5S AMPOULE]


name: GLYCERIN 2.04 g in 30 mL TOPICAL CREAM [RESURFACE MASK]


name: GLYCERIN 3.14 g in 50 mL TOPICAL CREAM [NYMPHSYN MAXIMIZER]


name: HYALURONIC ACID 0.15 g in 50 mL TOPICAL CREAM [HYALURON 3S SERUM]


name: SHEA BUTTER 2.4 g in 60 mL TOPICAL CREAM [ULTRA REPAIR]


name: WITCH HAZEL 3.0 g in 60 mL TOPICAL CREAM [HYDRA C3 TRIPLE RESET]


name: Titanium Dioxide 9.04 g in 45 g / Zinc Oxide 2.83 g in 45 g TOPICAL CREAM [SONATURAL POW DER4ROOM FIXING IT FULL COVER VANILLA BEIGE]


name: ADENOSINE 0.04 g in 100 mL TOPICAL LIQUID [DR. GLODERM TABRX WRINKLETOX MASK]


name: AMINO ACIDS, HAIR KERATIN 100 mg TOPICAL NOT APPLICABLE [keramatrix]


name: Dimethicone 0.06 g in 6 g TOPICAL POWDER [SONATURAL POW DER4ROOM MAKEUP HOLDING FINISH POW DER FIXER NATURAL YELLOW]


name: Dimethicone 0.12 g in 6 g TOPICAL POWDER [SONATURAL POW DER4ROOM MAKEUP HOLDING FINISH POW DER FIXER BRIGHT PINK]


name: Dimethicone 0.18 g in 1.5 g TOPICAL STICK [SONATURAL POW DER4ROOM SMUDGING ZERO REMOVER]


name: Dimethicone 1.5 g in 75 mL TOPICAL CREAM [SONATURAL HIGH WATER DRAW SUPER HYDRA BALM]


name: Dimethicone 5.0 g in 100 mL TOPICAL CREAM [SONATURAL FOR MEN STAY YOUNG ALL IN ONE FLUID]


name: GLYCERIN 1 g in 100 mL TOPICAL OIL [DR. GLODERM TABRX OILCAPSULE]


name: NIACINAMIDE 2 g in 100 mL TOPICAL LIQUID [DR. GLODERM TABRX WHITENING MASK]


name: Titanium Dioxide 9.04 g in 45 g / Zinc Oxide 2.83 g in 45 g TOPICAL CREAM [SONATURAL POW DER4ROOM FIXING IT FULL COVER NEUTRAL BEIGE]


name: Titanium Dioxide 1.15 g in 12 g / Octinoxate 0.84 g in 12 g / Zinc Oxide 0.58 g in 12 g / Octisalate 0.54 g in 12 g TOPICAL POWDER [QUEENS ROSE PERFECTION COVER CUSHION PACT]


name: OCTINOXATE 2.75 g in 50 g / OCTISALATE 2.5 g in 50 g / ENSULIZOLE 2.0 g in 50 g / AVOBENZONE 1.5 g in 50 g TOPICAL CREAM [QUEENS ROSE WHOLE IN ONE SUNBLOCK]


name: Titanium Dioxide 6.69 g in 50 g / Zinc Oxide 0.72 g in 50 g TOPICAL CREAM [QUEENS ROSE ROSE SKIN PERFECTION BB]


name: Niacinamide 0.6 g in 30 mL / Adenosine 0.012 g in 30 mL TOPICAL CREAM [QUEENS ROSE RECOVERY EYE]


name: Niacinamide 1.2 g in 60 g / Adenosine 0.024 g in 60 g TOPICAL CREAM [QUEENS ROSE RECOVERY]


name: Niacinamide 2.2 g in 110 mL / Adenosine 0.044 g in 110 mL TOPICAL EMULSION [QUEENS ROSE RECOVERY]


name: Niacinamide 2.4 g in 120 mL / Adenosine 0.048 g in 120 mL TOPICAL LIQUID [QUEENS ROSE RECOVERY TONER]


name: Dimethicone 0.9 g in 45 mL TOPICAL LIQUID [QUEENS ROSE RECOVERY SERUM]


name: Dimethicone 1.25 g in 50 g TOPICAL CREAM [QUEENS ROSE ELYSEE ESSENCE EYE]


name: Dimethicone 5.41 g in 50 g TOPICAL CREAM [QUEENS ROSE ELYSEE]


name: Glycerin 0.19 g in 8 g TOPICAL LIQUID [QUEENS ROSE ELYSEE CONCEN TRATE DUAL AMPOULE]


name: Supervision of pregnancy with history of abortive outcome (treatment)


name: Extracorporeal High-Intensity Focused Ultrasound Therapy


name: Sum of Products of Perpendicular Diameters


name: {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [Simpesse 91 Day]


name: Amputation of finger of left hand (procedure)


name: Physical findings:Find:Pt:Teeth and gum:Nar:Observed


name: Alpha-Methylacyl Coenzyme A Racemase Measurement


name: Procedure used to obtain tumor specimen:Type:Pt:Specimen:Nom


name: Blood pressure panel with all children optional:-:Pt:Arterial system:Qn


name: Porcine epidemic diarrhea virus S INDEL strain S gene:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Porcine epidemic diarrhea virus prototype & S INDEL strain S gene panel:-:Pt:XXX:-:Probe.amp.tar


name: Neutrophil.fMLP stimulated.DHR mean fluorescence intensity


name: Neutrophil.fMLP stimulated.DHR/Neutrophil.fMLP stimulated.total:NFr:Pt:Bld^Control:Qn:Flow cytometry


name: Neutrophil.PMA stimulated.DHR mean fluorescence intensity:Arb:Pt:Bld:Qn:Flow cytometry


name: Did your heart failure prevent you from living as you wanted during the past Mo (4W) by causing swelling in your ankles or legs


name: Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your working around the house or yard difficult


name: Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your relating to or doing things with your friends or family difficult:Find:1Mo:^Patient:Ord:MLHFQ


name: LCDS v3.00 - Mobility - discharge performance during 3D assessment period:-:3D:^Patient:-:CMS Assessment


name: Date of serology test^pre pregnancy:Date:Pt:^Mother:Qn


name: Neisseria meningitidis DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Streptococcus pneumoniae Danish serotype 19F Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 19F Ab^1st specimen:MCnc:Pt:Ser:Qn


name: Views for bone density:ArMass:Pt:Upper extremity>Humerus:Qn:DXA


name: Views for bone density:ArMass:Pt:Upper extremity.right>Humerus:Qn:DXA


name: Views for bone density:Tscore:Pt:Upper extremity.left>Humerus:Qn:DXA


name: IRF-PAI - Medical information:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI - Impairment group - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: Program return date:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Diagnosis for interruption or death:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Does the patient walk - discharge performance during 3D assessment period


name: Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 1.4


name: IRF-PAI - Functional abilities and goals - admission


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 3.00


name: Send document that conforms to Level 3 EMS R1 template


name: Send document that conforms to Level 3 EMS R1 template:Scope.modifier.doc template:Pt:X12^277:-


name: Cardiac implantable loop monitor study:Find:Stdy:Heart:Doc


name: Congenital rubella syndrome case classification:Imp:Pt:^Patient:Nom


name: Congenital rubella syndrome case classification


name: PROMIS short form - global - version 1.2 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - global - version 1.2 raw score


name: Salivary gland swelling duration:Time:Pt:^Patient:Qn


name: Note:Find:Pt:{Setting}:Doc:Maternal and fetal medicine


name: Health and well-being total:Score:Pt:^Patient:Qn:ePCAM


name: Lifestyle behaviors impacting physical or mental well-being - visual analog rating:Score:Pt:^Patient:Qn:ePCAM


name: Daily activities impact on well-being - visual analog rating:Score:Pt:^Patient:Qn:ePCAM


name: Influenza virus A & B & Respiratory syncytial virus RNA panel:-:Pt:Respiratory system specimen.upper:-:Probe.amp.tar


name: Influenza virus B RNA:PrThr:Pt:Respiratory system specimen.upper:Ord:Probe.amp.tar


name: Establishment registration exempt notification:-:-:^FDA product label:Nar


name: IRF-PAI - Therapy provided - week 2:-:RptPeriod:^Patient:-:CMS Assessment


name: Bacterial carbapenem resistance blaKPC gene:PrThr:Pt:Anorectal/isolate:Ord:Probe.amp.tar


name: PIK3CA gene targeted mutation analysis:Prid:Pt:Colorectal cancer specimen:Nom:Molgen


name: KRAS gene targeted mutation analysis:Prid:Pt:Colorectal cancer specimen:Nom:Molgen


name: Consultation note:Find:Pt:{Setting}:Doc:Child and adolescent psychology


name: Note:Find:Pt:{Setting}:Doc:Undersea and hyperbaric medicine


name: Mycoplasma hyopneumoniae P146 gene sequence & phylogenetic analysis:Find:Pt:XXX:Doc


name: Porcine reproductive and respiratory syndrome virus European strain Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Porcine reproductive and respiratory syndrome virus European strain Ab.IgG:PrThr:Pt:Ser:Ord:IF


name: Porcine reproductive and respiratory syndrome virus Ab.IgG/Positive control:RelRto:Pt:Saliva:Qn:IA


name: Porcine reproductive and respiratory syndrome virus European strain Ab.Neut:PrThr:Pt:Ser:Ord:Neut


name: Porcine reproductive and respiratory syndrome virus European & North American strains Ab.Neut panel:-:Pt:Ser:-:Neut


name: Influenza virus A porcine origin nucleoprotein Ab.IgA/Positive control:RelRto:Pt:XXX:Qn:IA


name: Physical therapy - co-treatment minutes^week 1:Time:RptPeriod:^Patient:Qn:CMS Assessment


name: Occupational therapy - individual minutes^week 1:Time:RptPeriod:^Patient:Qn:CMS Assessment


name: Occupational therapy - group minutes^week 1:Time:RptPeriod:^Patient:Qn:CMS Assessment


name: Occupational Therapy - co-treatment minutes^week 2:Time:RptPeriod:^Patient:Qn:CMS Assessment


name: Special treatments, procedures, and programs - discharge


name: Speech-language pathology services - group minutes


name: Title of person collecting or coordinating collection of assessment information


name: Against medical advice note:Find:Pt:{Setting}:Doc:{Role}


name: Chemokine (C-C Motif) Ligand 19 Measurement


name: {2 (0.4 ML adalimumab 100 MG/ML Auto-Injector [Humira]) / 1 (0.8 ML adalimumab 100 MG/ML Auto-Injector [Humira]) } Pack [Humira Pen 80 MG/0.8 ML and 40 MG/0.4 ML - Psoriasis/Uveitis Starter Package]


name: {3 (0.8 ML adalimumab 100 MG/ML Auto-Injector [Humira]) } Pack [Humira Pen 80 MG/0.8 ML - Starter Package for Crohn's Disease, Ulcerative Colitis or Hidradenitis Suppurativa]


name: {28 (letrozole 2.5 MG Oral Tablet [Femara]) / 21 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali Femara Co-Pack 200]


name: {28 (letrozole 2.5 MG Oral Tablet [Femara]) / 63 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali Femara Co-Pack 600]


name: {28 (letrozole 2.5 MG Oral Tablet [Femara]) / 42 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali Femara Co-Pack 400]


name: Speech-language pathology services - concurrent minutes^week 2:Time:RptPeriod:^Patient:Qn:CMS Assessment


name: Porcine reproductive and respiratory syndrome virus European strain ORF5 gene:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Porcine reproductive and respiratory syndrome virus European & North American strains Ab.IgG panel:-:Pt:Ser:-:IF


name: Preferred type of dialysis if required before transplant:Type:Pt:^Patient:Nom


name: Renal replacement therapy goals panel:-:Pt:^Patient:-:NKDEP


name: Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you stay in a hospital:Find:1Mo:^Patient:Ord:MLHFQ


name: Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making it difficult for you to concentrate or remember things:Find:1Mo:^Patient:Ord:MLHFQ


name: Kidney failure 5Y risk:Likelihood:Pt:^Patient:Qn:KFRE


name: Haemophilus influenzae hpd gene:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: LCDS v3.00 - Functional abilities and goals


name: Signature of person collecting or coordinating collection of assessment information:Pn:Pt:Provider:Nar


name: LCDS v3.00 - Signs and Symptoms of Delirium (from CAM):-:3D:^Patient:-:CMS Assessment


name: Was the patient's thinking disorganized or incoherent, such as rambling or irrelevant conversation, unclear or illogical flow of ideas, or unpredictable switching from subject to subject during 3D assessment period:Find:3D:^Patient:Ord:CAM.CMS


name: Occupation CDC Census code:Type:Pt:^Patient:Nom


name: LCDS v3.00 - Self-care - discharge goal:-:3D:^Patient:-:CMS Assessment


name: Haemophilus influenzae bex gene:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Haemophilus influenzae ecs gene:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Sexual activity with known Chlamydia trachomatis &or Neisseria gonorhoeae case:PrThr:Pt:^Patient:Ord


name: Previous rubella disease was serologically confirmed:Find:Pt:^Patient:Ord


name: Age at time of immunity testing:Time:Pt:^Patient:Qn


name: Has had previous deliveries in the U.S.:Find:Pt:^Mother:Ord


name: Gestational age in W^at cessation of pregnancy:Time:Pt:^Fetus:Qn


name: Non-agency caregiver ability and willingness to assist with advocacy or facilitation of patient participation


name: Rubella vaccine was received by children under the age of 18 in the household during the pregnancy:Find:Pt:^Mother:Ord


name: Streptococcus pneumoniae Danish serotype 4 DNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Streptococcus pneumoniae Danish serotype 14 DNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Streptococcus pneumoniae Danish serotypes 6A+6B+6C+6D DNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Streptococcus pneumoniae Danish serotypes 33A+33F+37 DNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Staphylococcus aureus DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Streptococcus agalactiae DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Klebsiella oxytoca DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Proteus sp DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Serratia marcescens DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Bacterial carbapenem resistance blaKPC gene:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Neisseria meningitidis serogroup DNA panel:-:Pt:XXX:-:Probe.amp.tar


name: Measles virus N gene:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Mumps virus SH gene:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Mumps virus RNA & SH gene panel:-:Pt:XXX:-:Probe.amp.tar


name: LCDS v4.00 - Patient demographic information - admission


name: Bacterial carbapenem resistance blaIMP gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Bacterial carbapenem resistance blaOXA-24-like gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial carbapenem resistance blaOXA-58-like gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial beta-lactam resistance ESBL blaCTX-M-9 group gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial beta-lactam resistance ESBL blaCTX-M-8+blaCTX-M-25 group genes:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial beta-lactam resistance ESBL blaPER gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: History and physical note:Find:Pt:{Setting}:Doc:Thoracic and cardiac surgery


name: Chemokine (C-C Motif) Ligand 7 Measurement


name: Note:Find:Pt:{Setting}:Doc:Thoracic and cardiac surgery.nurse


name: History and physical note:Find:Pt:Outpatient:Doc:Womens health


name: Group counseling note:Find:Pt:{Setting}:Doc:Womens health


name: Consultation note:Find:Pt:{Setting}:Doc:Community health care


name: Date of salivary gland swelling onset:Date:Pt:^Patient:Qn


name: Postoperative evaluation and management note:Find:Pt:{Setting}:Doc:Clinical cardiac electrophysiology


name: Preoperative evaluation and management note:Find:Pt:{Setting}:Doc:Gastroenterology


name: Preoperative evaluation and management note:Find:Pt:{Setting}:Doc:Pulmonary disease


name: Streptococcus pneumoniae Danish serotype 1 Ab.IgG:MCnc:Pt:Ser:Qn


name: Retinal nerve fiber layer.clock hour 4 thickness:Len:Pt:Retina.right:Qn:OCT


name: Retinal nerve fiber layer.clock hour 9 thickness


name: Retinal nerve fiber layer.clock hour 11 thickness:Len:Pt:Retina.right:Qn:OCT


name: Bacterial methicillin resistance mecA+mecC genes:PrThr:Pt:Nose:Ord:Probe.amp.tar


name: Bacterial methicillin resistance mecC gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Send document that conforms to Level 3 EMS R2 template:Scope.modifier.doc template:Pt:X12^277:-


name: Streptococcus pneumoniae Danish serotype 1 Ab.IgG^1st specimen:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 1 Ab.IgG^2nd specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 1 Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 12F Ab:PrThr:Pt:Ser:Ord


name: Streptococcus pneumoniae Danish serotype 12F Ab.IgG^1st specimen:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 12F Ab^2nd specimen:ACnc:Pt:Ser:Qn


name: How much time did you usually spend doing vigorous physical activities on one of those D


name: How much time did you usually spend doing moderate physical activities on one of those D


name: How much time did you usually spend walking on one of those D


name: Streptococcus pneumoniae Danish serotype 12F Ab^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 14 Ab:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 14 Ab.IgG^1st specimen:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 14 Ab.IgG^2nd specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 14 Ab^1st specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 14 Ab^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 17F Ab.IgG^1st specimen:MCnc:Pt:Ser:Qn:IA


name: Streptococcus pneumoniae Danish serotype 18F Ab^1st specimen:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 19F Ab:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 19F Ab.IgG:MCnc:Pt:Ser:Qn:IA


name: Streptococcus pneumoniae Danish serotype 19F Ab.IgG^2nd specimen:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 19F Ab^2nd specimen:ACnc:Pt:Ser:Qn:IA


name: Streptococcus pneumoniae Danish serotype 19F Ab^2nd specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 2 Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 20A Ab.IgG:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 20A Ab.IgG^1st specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 22F Ab.IgG^1st specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 22F Ab.IgG^2nd specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 22F Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 23F Ab.IgG:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 23F Ab.IgG^1st specimen:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 23F Ab.IgG^2nd specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 23F Ab^2nd specimen:ACnc:Pt:Ser:Qn:IA


name: Streptococcus pneumoniae Danish serotype 23F Ab^2nd specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 3 Ab:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 3 Ab.IgG^1st specimen:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 3 Ab.IgG^2nd specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 3 Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 3 Ab^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 10A Ab.IgG^1st specimen:MCnc:Pt:Ser:Qn:IA


name: Streptococcus pneumoniae Danish serotype 4 Ab.IgG:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 4 Ab.IgG:MCnc:Pt:Ser:Qn:IA


name: Streptococcus pneumoniae Danish serotype 4 Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Views diagnostic for technical call back:Find:Pt:Breast:Doc:MG


name: Actinobacillus pleuropneumoniae serotype 3 Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: Streptococcus pneumoniae Danish serotype 4 Ab.IgG^1st specimen:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 4 Ab^2nd specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 11A Ab.IgG:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 11A Ab.IgG^1st specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 5 Ab.IgG:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 5 Ab.IgG^1st specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 5 Ab.IgG^2nd specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 8 Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Streptococcus pneumoniae Danish serotype 8 Ab.IgG^1st specimen:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 8 Ab.IgG^2nd specimen:MCnc:Pt:Ser:Qn:IA


name: Streptococcus pneumoniae Danish serotype 8 Ab^2nd specimen:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 9N Ab:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 9N Ab:PrThr:Pt:Ser:Ord


name: Streptococcus pneumoniae Danish serotype 9N Ab.IgG^1st specimen:MCnc:Pt:Ser:Qn:IA


name: Streptococcus pneumoniae Danish serotype 9N Ab.IgG^2nd specimen:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 9N Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 9N Ab^2nd specimen:ACnc:Pt:Ser:Qn


name: Neisseria meningitidis serogroup Y synF gene:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Degree of difficulty experienced due to your hip while bending to floor &or pick up an object in the last W:Find:1W:^Patient:Ord:HOOS


name: Degree of difficulty experienced due to your hip while sitting in the last W


name: Porcine epidemic diarrhea virus:PrThr:Pt:XXX:Ord:Organism specific culture


name: Porcine epidemic diarrhea virus Ab.IgG:PrThr:Pt:Ser:Ord:IF


name: Note:Find:Pt:{Setting}:Doc:Community health care.case manager


name: Retinal nerve fiber layer.nasal thickness:Len:Pt:Retina.right:Qn:OCT


name: Diagnostic mammogram & ultrasound panel:Find:Pt:Breast.left:Doc


name: Guidance for needle localization:Find:Pt:Breast.left:Doc:MG


name: Diagnostic mammogram & ultrasound panel:Find:Pt:Breast.right:Doc


name: Sexual activity in the last Y:Find:1Y:^Patient:Ord:Reported


name: Reason for no birth control use^at intake:Find:Pt:^Patient:Nom:Reported


name: Rotavirus A VP6 capsid protein:PrThr:Pt:XXX:Ord:IA


name: Porcine epidemic diarrhea virus Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Bacterial colistin resistance mcr-1 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Neisseria meningitidis serogroup A sacB gene:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Neisseria meningitidis serogroup C synE gene:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Retinal nerve fiber layer.temporal thickness:Len:Pt:Retina.right:Qn:OCT


name: Retinal nerve fiber layer.temporal superior thickness:Len:Pt:Retina.left:Qn:OCT


name: Retinal nerve fiber layer.inferior temporal thickness:Len:Pt:Retina.right:Qn:OCT


name: Retinal nerve fiber layer.inferior thickness:Len:Pt:Retina.left:Qn:OCT


name: Retinal nerve fiber layer.mean thickness:Len:Pt:Retina.left:Qn:OCT


name: Retinal nerve fiber layer.clock hour 4 thickness:Len:Pt:Retina.left:Qn:OCT